Last edition
News about "US pharmaceutical market"
Lupin Launches Diabetes Drug Combination in the US
Lupin launches dapagliflozin and metformin extended-release tablets in the US, offering a bioequivalent and cost-effective alternative for type 2 diabetes management.
US Pharmaceutical Market | 22/04/2026 | By News Bureau | 107
Glenmark Takes Charge of RYALTRIS Commercialisation in US
Glenmark will handle end-to-end commercialisation and distribution of RYALTRIS nasal spray in the US, strengthening its respiratory portfolio presence.
US Pharmaceutical Market | 06/04/2026 | By News Bureau | 248
Alembic Pharmaceuticals reports first prescription sale of Pivya in the US, marking its entry into the branded pharmaceutical segment with a first-line oral antibiotic for uncomplicated urinary tract infections in women.
US Pharmaceutical Market | 07/03/2026 | By News Bureau | 121
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy